EQRx Funding & Investors
EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. Headquartered in Cambridge, Massachusetts, the company is backed by GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech, and Arboretum Ventures.
https://www.eqrx.com/Total Amount Raised: $1,900,000,000
EQRx Funding Rounds
Post Ipo Equity
$1,200,000,000
Post Ipo Equity Investors
SB Life ScienceAvidity Partners ManagementVerily Life SciencesRock Springs CapitalCasdin CapitalFidelity InvestmentsAndreessen HorowitzBiotechnology Value FundMubadala Capital VenturesCorvexMubadalaInvusBoxer CapitalFranklin ResourcesBain Capital Life SciencesSeries B
$500,000,000
Series B Investors
Arch Venture PartnersAndreessen HorowitzGVArboretum VenturesNextech InvestSection 32Casdin CapitalBain Capital Life SciencesSeries A
$200,000,000
Series A Investors
GVNextech InvestAndreessen HorowitzArboretum VenturesArch Venture PartnersCasdin CapitalSection 32Bain Capital Life SciencesExor Ventures
Funding info provided by Diffbot.